4554.T Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 apr 2024 @ 08:15):

Stats
Dagens volum	47 800.00
Gjennomsnittsvolum	212 075
Markedsverdi	38.62B
EPS	¥0 ( 2024-02-07 )
Neste inntjeningsdato	( ¥0 ) 2024-05-08
Last Dividend	¥17.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	7.63
ATR14	¥1.391 (0.09%)

Volum Korrelasjon

Lang: -0.05 (neutral)

Kort: -0.03 (neutral)

Signal:(53.268) Neutral

Fuji Pharma Co., Ltd. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Fuji Pharma Co., Ltd. Korrelasjon - Valuta/Råvare

-0.11
( neutral )

-0.52
( weak negative )

-0.88
( strong negative )

-0.58
( weak negative )

0.55
( weak )

0.42
( neutral )

Fuji Pharma Co., Ltd. Økonomi

Annual	2023
Omsetning:	¥40.89B
Bruttogevinst:	¥16.52B (40.39 %)
EPS:	¥141.35

FY	2023
Omsetning:	¥40.89B
Bruttogevinst:	¥16.52B (40.39 %)
EPS:	¥141.35

FY	2022
Omsetning:	¥35.43B
Bruttogevinst:	¥14.56B (41.10 %)
EPS:	¥110.98

FY	2021
Omsetning:	¥33.99B
Bruttogevinst:	¥14.75B (43.40 %)
EPS:	¥78.06

Financial Reports:

No articles found.

Fuji Pharma Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥20.00 (N/A)	¥0 (N/A)	¥17.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Fuji Pharma Co., Ltd. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 8.73 - good (87.28%) | Divividend Growth Potential Score: 5.58 - Stable (11.66%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥6.50	2010-03-29
Last Dividend	¥17.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	¥321.00	--
Avg. Dividend % Per Year	0.00%	--
Score	3.43	--
Div. Sustainability Score	8.73
Div.Growth Potential Score	5.58
Div. Directional Score	7.16	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.43

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6879.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6250.T	Ex Dividend Knight	2023-12-28	Annually	0.00%
4970.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4182.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3361.T	Ex Dividend Junior	2024-04-26	Annually	0.00%
2438.T	Ex Dividend Junior	2024-04-26	Annually	0.00%
9380.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
8060.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
7326.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
6571.T	Ex Dividend Junior	2024-06-27	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.122	1.500	7.57	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0598	1.200	8.01	9.61	[0 - 0.3]
returnOnEquityTTM	0.123	1.500	9.74	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.458	0.800	7.71	6.17	[1 - 3]
quickRatioTTM	0.610	0.800	-1.120	-0.896	[0.8 - 2.5]
cashRatioTTM	0.0780	1.500	-0.678	-1.017	[0.2 - 2]
debtRatioTTM	0.324	-1.500	4.61	-6.91	[0 - 0.6]
interestCoverageTTM	20.55	1.000	3.50	3.50	[3 - 30]
operatingCashFlowPerShareTTM	259.78	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	259.78	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.652	-1.500	7.39	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.385	1.000	6.92	6.92	[0.2 - 0.8]
operatingProfitMarginTTM	0.0607	1.000	-0.786	-0.786	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.231	1.000	9.83	9.83	[0.2 - 2]
assetTurnoverTTM	0.492	0.800	-0.0514	-0.0411	[0.5 - 2]
Total Score				8.73

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.64	1.000	9.33	0	[1 - 100]
returnOnEquityTTM	0.123	2.50	9.83	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	259.78	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.52	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	259.78	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.279	1.500	-1.473	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.152	1.000	8.71	0	[0.1 - 0.5]
Total Score				5.58

Fuji Pharma Co., Ltd.

Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.